Response by Siontis et al to Letter Regarding Article, "Outcomes Associated With Apixaban Use in Patients With End-Stage Kidney Disease and Atrial Fibrillation in the United States".

Response by Siontis et al to Letter Regarding Article, "Outcomes Associated With Apixaban Use in Patients With End-Stage Kidney Disease and Atrial Fibrillation in the United States". Circulation. 2019 Mar 19;139(12):1563-1564 Authors: Siontis KC, Zhang X, Schaubel DE, Yao X, Noseworthy PA, Shah ND, Saran R, Nallamothu BK PMID: 30883218 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/30883218?dopt=Abstract

Source: Circulation - March 18, 2019 Category: Cardiology Authors: Siontis KC, Zhang X, Schaubel DE, Yao X, Noseworthy PA, Shah ND, Saran R, Nallamothu BK Tags: Circulation Source Type: research

More News: Atrial Fibrillation | Cardiology | Urology & Nephrology | USA Health